Publication | Closed Access

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

Breast OncologyPrognostic RoleMedicinePharmacologyPathologyBreast CancerCancer TreatmentOncologyRadiation OncologyCancer ResearchEndocrine-related Cancer